Female Reproductive System Clear Cell Adenocarcinoma

Female Reproductive System Clear Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 27
Recruiting: 11
Ph III recruiting: 3
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–24 of 24 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04719273	Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer	completed	Phase 2	14	Thomas Jefferson UniversityOTHER	1	Jul 17, 2026	clinicaltrials
NCT02122185	Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	completed	Phase 2	111	University of ChicagoOTHER	1	Mar 27, 2026	clinicaltrials